1. Apoptosis Metabolic Enzyme/Protease
  2. Endogenous Metabolite Apoptosis
  3. Beta-Sitosterol (purity>80%)

Beta-Sitosterol (purity≥80%) is orally active. Beta-Sitosterol exhibits multiple activities, including anti-inflammatory, anticancer, antioxidant, antimicrobial, antidiabetic, antioxidant enzyme, and analgesic. Beta-Sitosterol inhibits inflammation and impaired adipogenesis in bovine mammary epithelial cells by reducing levels of ROS, TNF-α, IL-1β, and NF-κB p65 and restoring the activity of the HIF-1α/mTOR signaling pathway. Beta-Sitosterol induces apoptosis in cancer cells through ROS-mediated mitochondrial dysregulation and p53 activation. Beta-Sitosterol exerts its anticancer effects in cancer cells by activating caspase-3, caspase-8, and caspase-9, mediating PARP inactivation, MMP loss, altered Bcl-2-Bax ratio, and cytochrome c release. Beta-Sitosterol modulates macrophage polarization and reduces rheumatoid inflammation in mice. Beta-Sitosterol inhibits tumor growth in multiple mouse cancer models. Beta-Sitosterol can be used in the research of arthritis, lung cancer, breast cancer and other cancers, diabetes, etc.

For research use only. We do not sell to patients.

CAS No. : 83-46-5

Size Price Stock Quantity
100 mg In-stock
1 g In-stock
5 g In-stock
10 g   Get quote  
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 20 publication(s) in Google Scholar

Other Forms of Beta-Sitosterol (purity>80%):

Top Publications Citing Use of Products

    Beta-Sitosterol (purity>80%) purchased from MedChemExpress. Usage Cited in: Front Oncol. 2022 Aug 10;12:882784.  [Abstract]

    TNBC cells were simultaneously treated with quercetin and/or β-sitosterol for 48 h. Cell viability was measured via CCK-8 assay.

    Beta-Sitosterol (purity>80%) purchased from MedChemExpress. Usage Cited in: Front Oncol. 2022 Aug 10;12:882784.  [Abstract]

    Mice were administered β-sitosterol (75 mg/kg) each day via oral gavage. Nude mice were subcutaneously injected with MDA-MB-231 cells. Representative images showed the dissected tumors in distinct treatment groups as specified at the endpoint.

    Beta-Sitosterol (purity>80%) purchased from MedChemExpress. Usage Cited in: Front Oncol. 2022 Aug 10;12:882784.  [Abstract]

    Mice were administered β-sitosterol (75 mg/kg) each day via oral gavage. Tumor lysates were collected, and the protein profile was established by immunoblotting analysis.

    Beta-Sitosterol (purity>80%) purchased from MedChemExpress. Usage Cited in: Biosci Rep. 2020 Oct 30;40(10):BSR20201349.  [Abstract]

    Beta-sitosterol (5–100 μM; 48 h). Different concentrations of active compounds on improvement rate.

    Beta-Sitosterol (purity>80%) purchased from MedChemExpress. Usage Cited in: Biosci Rep. 2020 Oct 30;40(10):BSR20201349.  [Abstract]

    Beta-Sitosterol (40 μM; 30 min) reduced IL-6 concentration.

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Beta-Sitosterol (purity≥80%) is orally active. Beta-Sitosterol exhibits multiple activities, including anti-inflammatory, anticancer, antioxidant, antimicrobial, antidiabetic, antioxidant enzyme, and analgesic. Beta-Sitosterol inhibits inflammation and impaired adipogenesis in bovine mammary epithelial cells by reducing levels of ROS, TNF-α, IL-1β, and NF-κB p65 and restoring the activity of the HIF-1α/mTOR signaling pathway. Beta-Sitosterol induces apoptosis in cancer cells through ROS-mediated mitochondrial dysregulation and p53 activation. Beta-Sitosterol exerts its anticancer effects in cancer cells by activating caspase-3, caspase-8, and caspase-9, mediating PARP inactivation, MMP loss, altered Bcl-2-Bax ratio, and cytochrome c release. Beta-Sitosterol modulates macrophage polarization and reduces rheumatoid inflammation in mice. Beta-Sitosterol inhibits tumor growth in multiple mouse cancer models. Beta-Sitosterol can be used in the research of arthritis, lung cancer, breast cancer and other cancers, diabetes, etc[1][2][3][4][5][6][7][8][9][10][11][12][13].

    Cellular Effect
    Cell Line Type Value Description References
    1A9 ED50
    10.6 μg/mL
    Compound: 17
    Cytotoxicity against human 1A9 cells after 6 days by SRB assay
    Cytotoxicity against human 1A9 cells after 6 days by SRB assay
    [PMID: 14640511]
    1A9 ED50
    16.8 μg/mL
    Compound: 17
    Cytotoxicity against human 1A9 cells after 3 days by SRB assay
    Cytotoxicity against human 1A9 cells after 3 days by SRB assay
    [PMID: 14640511]
    1A9/ptx-10 ED50
    20 μg/mL
    Compound: 17
    Cytotoxicity against human 1A9/PTX10 cells after 3 days by SRB assay
    Cytotoxicity against human 1A9/PTX10 cells after 3 days by SRB assay
    [PMID: 14640511]
    1A9/ptx-10 ED50
    9.5 μg/mL
    Compound: 17
    Cytotoxicity against human 1A9/PTX10 cells after 6 days by SRB assay
    Cytotoxicity against human 1A9/PTX10 cells after 6 days by SRB assay
    [PMID: 14640511]
    A2780 IC50
    > 10 μg/mL
    Compound: page 1629, R26C1
    Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
    Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    A549 ED50
    > 20 μg/mL
    Compound: 17
    Cytotoxicity against human A549 cells after 3 days by SRB assay
    Cytotoxicity against human A549 cells after 3 days by SRB assay
    [PMID: 14640511]
    A549 IC50
    > 10 μg/mL
    Compound: page 1629, R26C1
    Cytotoxicity against human A549 cells after 96 hrs by MTT assay
    Cytotoxicity against human A549 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    BGC-823 IC50
    > 10 μg/mL
    Compound: page 1629, R26C1
    Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
    Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    Bel-7402 IC50
    > 10 μg/mL
    Compound: page 1629, R26C1
    Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
    Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    ECV-304 IC50
    472 μM
    Compound: Beta-sitosterol
    Membrane toxicity against human ECV304 cells after 2 hrs by LDH release assay
    Membrane toxicity against human ECV304 cells after 2 hrs by LDH release assay
    [PMID: 24084294]
    ECV-304 IC50
    472 μM
    Compound: beta-sitosterol
    Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry
    Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry
    [PMID: 22503361]
    ECV-304 IC50
    61 μM
    Compound: Beta-sitosterol
    Cytotoxicity against human ECV304 cells after 72 hrs by MTT assay
    Cytotoxicity against human ECV304 cells after 72 hrs by MTT assay
    [PMID: 24084294]
    ECV-304 IC50
    61 μM
    Compound: beta-sitosterol
    Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay
    Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay
    [PMID: 22503361]
    HCT-8 ED50
    > 20 μg/mL
    Compound: 17
    Cytotoxicity against human HCT8 cells after 3 days by SRB assay
    Cytotoxicity against human HCT8 cells after 3 days by SRB assay
    [PMID: 14640511]
    HCT-8 IC50
    > 10 μg/mL
    Compound: page 1629, R26C1
    Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    HEp-2 IC50
    11.4 μM
    Compound: 119
    Antiproliferative activity against human Hep2 cells by MTT assay
    Antiproliferative activity against human Hep2 cells by MTT assay
    [PMID: 30830783]
    HT-1080 IC50
    2.5 μM
    Compound: Angelicin
    Cytotoxicity against human HT1080 cells assessed as reduction in cell viability
    Cytotoxicity against human HT1080 cells assessed as reduction in cell viability
    [PMID: 30660827]
    HUVEC ED50
    > 5 μg/mL
    Compound: beta-sitosterol
    Cytotoxicity against HUVEC
    Cytotoxicity against HUVEC
    [PMID: 15043409]
    HeLa IC50
    46.22 μM
    Compound: 9
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    [PMID: 19447618]
    J774 IC50
    > 241.1 μM
    Compound: 11
    Cytotoxicity against mouse J774 cells by alamar blue assay
    Cytotoxicity against mouse J774 cells by alamar blue assay
    [PMID: 17637068]
    KB ED50
    > 20 μg/mL
    Compound: 17
    Cytotoxicity against human KB cells after 3 days by SRB assay
    Cytotoxicity against human KB cells after 3 days by SRB assay
    [PMID: 14640511]
    KB IC50
    > 10 μg/mL
    Compound: 119
    Antiproliferative activity against human KB cells assessed as reduction in cell viability
    Antiproliferative activity against human KB cells assessed as reduction in cell viability
    [PMID: 30830783]
    KB IC50
    > 241.5 μM
    Compound: 119
    Antiproliferative activity against human KB/HeLa cells assessed as reduction in cell viability
    Antiproliferative activity against human KB/HeLa cells assessed as reduction in cell viability
    [PMID: 30830783]
    LNCaP ED50
    > 5 μg/mL
    Compound: beta-sitosterol
    Cytotoxicity against human LNCAP cells
    Cytotoxicity against human LNCAP cells
    [PMID: 15043409]
    Lu1 ED50
    > 5 μg/mL
    Compound: beta-sitosterol
    Cytotoxicity against human Lu1 cells
    Cytotoxicity against human Lu1 cells
    [PMID: 15043409]
    MCF7 ED50
    > 20 μg/mL
    Compound: 17
    Cytotoxicity against human MCF7 cells after 3 days by SRB assay
    Cytotoxicity against human MCF7 cells after 3 days by SRB assay
    [PMID: 14640511]
    MCF7 ED50
    > 5 μg/mL
    Compound: beta-sitosterol
    Cytotoxicity against human MCF7 cells
    Cytotoxicity against human MCF7 cells
    [PMID: 15043409]
    MCF7 IC50
    42.1 μM
    Compound: 9
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    [PMID: 19447618]
    PC-3 ED50
    > 20 μg/mL
    Compound: 17
    Cytotoxicity against human PC3 cells after 3 days by SRB assay
    Cytotoxicity against human PC3 cells after 3 days by SRB assay
    [PMID: 14640511]
    SK-MEL-1 IC50
    > 50 μM
    Compound: 9
    Cytotoxicity against human SK-MEL-1 cells by MTT assay
    Cytotoxicity against human SK-MEL-1 cells by MTT assay
    [PMID: 19447618]
    U-87MG ATCC ED50
    > 20 μg/mL
    Compound: 17
    Cytotoxicity against human U87MG cells after 3 days by SRB assay
    Cytotoxicity against human U87MG cells after 3 days by SRB assay
    [PMID: 14640511]
    Vero IC50
    > 128 μg/mL
    Compound: 4
    Cytotoxicity against african green monkey Vero cells
    Cytotoxicity against african green monkey Vero cells
    [PMID: 18818073]
    In Vitro

    Bioactivity-guided isolation afforded three compounds from the hexane fraction of E. indica, namely, Beta-Sitosterol (β-sitosterol), Stigmasterol, and Lutein. Both compounds are found to possess very low PPL inhibition activity, that is, 2.99±0.80% (Beta-Sitosterol) of inhibition at 100 μg/mL (242 μM) and 2.68±0.38% (Stigmasterol) of inhibition at 100 μg/mL (243 μM), respectively. Weak PPL inhibition activity of Beta-Sitosterol and Stigmasterol isolated from Alpinia zerumbet with IC50 value of 99.99±1.86 μg/mL and 125.05±4.76 μg/mL, respectively, in comparison with the inhibition shown by Curcumin (IC50=4.92±0.21 μg/mL) and Quercetin (IC50=18.60±0.86 μg/mL) which are used as positive controls in their study. Beta-Sitosterol and Stigmasterol are recorded with weak PPL inhibitory activity of only 3.0±0.8% and 2.7±0.4% at 100 μg/mL, respectively, (i.e., 242 μM and 243 μM) in contrast (34.5±5.4% at 100 μg/mL), which are comparatively lower than that recorded in literature (i.e., 50% PPL inhibition at 100 μg/mL)[1]. Sitosterol is an important compound extracted from the leaves of Aloe vera. It inhibits the growth of promastigotes of L. donovani, a causative agent for life threatening visceral leishmaniasis disease[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Beta-Sitosterol (β-sitosterol) treatment significantly reduced the immobility time at three doses (10, 20, and 30 mg/kg) in the Forced Swim Test (FST) and Tail Suspension Test (TST), indicating an antidepressant effect. This effect is similar to the positive control fluoxetine at a dose of 30 mg/kg, where the strongest effect is observed compared with the control group (P < 0.001). The same effects are observed for three doses of Beta-Sitosterol in the TST. The % DID values are as follows: FST: 39.27% (10 mg/kg), 51.23% (20 mg/kg), and 57.48% (30 mg/kg); TST: 31.63% (10 mg/kg), 43.95% (20 mg/kg), and 53.38% (30 mg/kg). These results indicate that Beta-Sitosterol has a significant antidepressant activity in mice during the FST and TST. Furthermore, Beta-Sitosterol exhibits the antidepressant effect in a dose-dependent manner[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    414.71

    Formula

    C29H50O

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    CC[C@@H](C(C)C)CC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    -20°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    Solvent & Solubility
    In Vitro: 

    Ethanol : 4 mg/mL (9.65 mM; ultrasonic and warming and heat to 60°C)

    DMSO : < 1 mg/mL (insoluble or slightly soluble)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.4113 mL 12.0566 mL 24.1132 mL
    5 mM 0.4823 mL 2.4113 mL 4.8226 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 20 mg/mL (48.23 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: ≥98.0%

    References
    Animal Administration
    [3]

    Mice[3]
    Male ICR mice (20±2 g) and male KunMing mice (20±2 g) are used. Local breed, male ICR mice (20±2 g) are used in the FST under standard conditions with free access to food and water. Mice are randomly divided into four groups (8 mice per group are used) for the tail suspension test (TST): Beta-Sitosterol (10, 20, and 30 mg/kg), total sterols (50, 100, and 200 mg/kg), fluoxetine (20 mg/kg), or distilled water. 80 male mice are used. Briefly, the vehicle or test drugs are administered 30 min before a test session acute ip injection. Then, mice are individually suspended by tail with clamp (2 cm from the tip of the end) in a box (25 cm×25 cm×30 cm) with the head 5 cm to the bottom. Testing is carried out in a darkened room with minimal background noise. All animals are suspended for total 6 min, and the duration of immobility is observed and measured during the final 4-min interval of the test. All test sessions are recorded by a video camera positioned directly above the box. Two competent observers blind to treatment scored the videotapes. Mice consider immobile only when they hung passively and completely motionless. The animals are used only once in this test. All TSTs are performed between 11:00 A.M. and 14:00 P.M.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    Ethanol 1 mM 2.4113 mL 12.0566 mL 24.1132 mL 60.2831 mL
    5 mM 0.4823 mL 2.4113 mL 4.8226 mL 12.0566 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Beta-Sitosterol (purity>80%)
    Cat. No.:
    HY-N0171
    Quantity:
    MCE Japan Authorized Agent: